Aortic Stenosis with High Gradients and Area >1: Just Follow Up?

Definig severe aortic stenosis (AS) rests upon Doppler parameters, and uses log-established cutoff values, which include peak velocity (PV) ≥ 4 m/s, mean gradient (MG) ≥ 40 mmHg and aortic valve area (AVA) ≤ 1 cm². However, there are value discrepancies in up to 30-40% of cases, which has given way to different clinical profiles. 

angulación aórtica post TAVR

One of the discrepant phenotypes corresponds to patients with high gradients (HG) and AVA > 1 cm². Their management and prognosis has hardly been approached by clinical guidelines. The aim of this study was to look into the clinical and hemodynamic characteristics of this group and compare their mortality against other AS subtypes. 

This was a retrospective study on echocardiographic data from the Mayo Clinic (Minnesota, EE. UU.). It included patients with AS diagnosis classified according to AVA, PV and MG into four groups. Patients with prior valve surgery, left ventricular outflow tract obstruction, mitral or aortic insufficiency or mitral stenosis were excluded. Primary outcome was all cause mortality. 

Data from 3,209 were collected, distributed by hemodynamic characteristics as follows: 7.2% phenotype AG-AVA > 1, 45.9% phenotype HG-AVA ≤ 1, 14.3% low gradient phenotype with AVA ≤ 1 (LG-AVA ≤ 1), and 32.6% moderate AS.

HG-AVA > 1 patient mean age was 70.2 ± 12 years, making this the youngest of subtypes (P < 0.01), also presenting higher prevalence of male sex (85.7%), larger body surface and body mass index (BMI), and higher incidence of bicuspid aortic valve (39.6%). They had fewer comorbidities and lower levels of natriuretic peptide type B (BNP). PV and MG values were lower vs. phenotype AVA ≤ 1 (P < 0.01), while 115.0 ± 19 mL systolic volume (SV) and 54.8 ± 10.5 mL/m² indexed value (SV index) were higher.

Read also: SCAAR Registry: Coronary Angioplasty in Venous Grafts.

During a 944-day followup, there were 1,523 deaths (47.5%). Phenotype HG-AVA > 1 presented 38.9% mortality rate at 5 years, and 59.6% at 8 years. After adjusting for age, mortality in this group resulted similar to that of moderate AS patients, but lower vs. phenotype LG-AVA ≤ 1 (HR: 1.9 [CI 95%: 1.4-2.4]; P < 0.01).

As regards aortic valve replacement (AVR), mainly surgical (12.9% were TAVR), 67.4% of patients with HG-AVA > 1 were treated, vs. 69% of HG-AVA ≤ 1, 32.8% of LG-AVA ≤ 1 and 34.7% of moderate AS patients. Mortality in AVR patients, resulted higher in patients with AVA ≤ 1, both for HG (HR: 1.5 [CI 95%: 1.1-2.0]; P = 0.03) and LG patients (HR: 2.4 [CI 95%: 1.6-3.5]; P < 0.001).

Mortality rate for patients with HG-AVA > 1 undergoing AVR was superior to that of one controlled matched population, but significantly lower to that of HG-AVA > 1 patients not operated on (mortality rate 8.2 [CI 95%: 5.9-11.2]).

Conclusions

In this cohort of patients with AS, individuals with high gradients and > 1 cm² valve area were characterized for being younger, and have lower comorbidities vs. other phenotypes. Presented higher survival, expect for a matched population. Aortic valve replacement showed an 8-year survival benefit vs. the non-treated, which suggests a positive impact of surgery for this specific group. 

Original Title: High-Gradient Aortic Stenosis With Valve Area >1.0 cm2 The “Forgotten” Discordant Hemodynamic Phenotype.

Reference: Ito S, Oh JK, Michelena HI, Egbe AC, Connolly HM, Pellikka PA, Nkomo VT, Lewis BR, Miranda WR. High-Gradient Aortic Stenosis With Valve Area >1.0 cm2: The “Forgotten” Discordant Hemodynamic Phenotype. JACC Cardiovasc Imaging. 2024 Sep 5:S1936-878X(24)00315-2. doi: 10.1016/j.jcmg.2024.07.025. Epub ahead of print. PMID: 39297851.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Omar Tupayachi
Dr. Omar Tupayachi
Member of the Editorial Board of solaci.org

More articles by this author

Long-Term Predictors of Valve Deterioration After TAVI

Transcatheter aortic valve implantation (TAVI) has become an innovative technology for the treatment of patients with severe aortic valve stenosis. Initially implemented in elderly...

Coronary access after TAVI with fourth- and fifth-generation Evolut valves: the EPROMPT-CA study

The expansion of transcatheter aortic valve implantation (TAVI) toward younger and lower-risk patients has increased the relevance of post-procedural coronary access. In this context,...

TEER plus optimal medical therapy versus medical therapy alone in functional mitral regurgitation

Mitral regurgitation (MR) is a highly prevalent valvular heart disease that, in advanced stages and when left untreated, is associated with reduced quality of...

VECTOR: First Percutaneous Aorto-Coronary Bypass Case, a New Conceptual Approach

Coronary obstruction represents one of the most severe complications associated with transcatheter aortic valve implantation, particularly in valve-in-valve scenarios involving surgical bioprostheses, narrow aortic...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Duration of Smoking Cessation and Risk of Amputation After Revascularization in Critical Limb Ischemia

Critical limb ischemia (CLI) is associated with high rates of amputation and mortality. Although smoking cessation improves outcomes after revascularization, the impact of the...

Conservative management of endoleaks in complex aortic endografts under CT angiography follow-up

Endoleaks remain one of the leading causes of reintervention after endovascular repair of complex aortic aneurysms using fenestrated and/or branched endografts (F/B-EVAR). Traditionally, type...

Long-Term Predictors of Valve Deterioration After TAVI

Transcatheter aortic valve implantation (TAVI) has become an innovative technology for the treatment of patients with severe aortic valve stenosis. Initially implemented in elderly...